Are higher vancomycin doses needed in ventricle-external shunted patients?

Area of Science:

• Pharmacokinetics
• Neurosurgery
• Infectious Diseases

Background:

• Hydrocephalus management often involves cerebrospinal fluid shunting.
• Vancomycin is a critical antibiotic for treating infections, especially in neurosurgical patients.
• Understanding vancomycin pharmacokinetics in shunted patients is essential for effective treatment.

Purpose of the Study:

• To characterize vancomycin pharmacokinetic parameters in patients with cerebrospinal fluid shunts.
• To determine optimal vancomycin dosage regimens for shunted patients.
• To compare vancomycin pharmacokinetics and dosage requirements between shunted patients and controls.

Main Methods:

• Retrospective analysis of vancomycin blood concentrations from a Therapeutic Drug Monitoring (TDM) program.
• Inclusion of ventricle-external shunted patients (Group A) and control subjects (Group B).
• Estimation of individual pharmacokinetic parameters (clearance, volume of distribution) using a one-compartmental model and Bayesian analysis for dosage adjustment.

Main Results:

• Significant differences in vancomycin clearance (CL) were observed between shunted patients and controls (CL(A) vs. CL(B)).
• No significant difference in the volume of distribution (V) was found between the groups (V(A) vs. V(B)).
• Shunted patients required significantly higher daily vancomycin doses (49.25 mg/kg/day) compared to controls (31.74 mg/kg/day) to achieve target concentrations.

Conclusions:

• Shunted patients exhibit greater vancomycin clearance, necessitating higher daily doses.
• Vancomycin Therapeutic Drug Monitoring (TDM) is strongly recommended for shunted patients.
• Ensuring antibiotic blood concentrations within the therapeutic range is vital for optimal outcomes in this population.